Antiviral Agents, 2024
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 65
Special Issue Editor
Interests: antiviral; helicase; polymerase; protease; arbovirus; influenza and HCV
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antiviral agents are useful in tackling viral diseases where there is a lack of an effective vaccine or infection has already taken place. The viral cycle uses the host cell metabolism to replicate, and drug targets which are restricted to the virus are limited. Thus, the search for effective and selective antiviral compounds is an urgent. Our Special Issue celebrates natural and synthetic antiviral compounds with effects evaluated by phenotypical and molecular assays.
Dr. Luis Octavio Regasini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiviral
- virus
- arbovirus
- drugs
- protease
- helicase
- polymerase
- reverse transcriptase
